AIM
AIM ImmunoTech
35 hedge funds and large institutions have $15.5M invested in AIM ImmunoTech in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$345K | |
| 2 | +$299K | |
| 3 | +$144K | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$118K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$103K |
Top Sellers
| 1 | -$702K | |
| 2 | -$336K | |
| 3 | -$234K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$170K |
| 5 |
VF
Virtu Financial
New York
|
-$67K |